Singapore markets open in 7 hours 14 minutes
Straits Times Index
3,313.35 +9.69 (+0.29%) S&P 500
5,225.57 +4.15 (+0.08%) Dow
39,412.08 -19.43 (-0.05%) Nasdaq
16,444.28 +56.04 (+0.34%) Bitcoin USD
61,205.24 -1,507.96 (-2.40%) CMC Crypto 200
1,264.86 -26.54 (-2.05%)
GILD Jun 2024 61.000 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 10:52AM EDT. Market open.
| Previous close | 4.52 |
| Open | 7.02 |
| Bid | 6.30 |
| Ask | 6.55 |
| Strike | 61.00 |
| Expiry date | 2024-06-07 |
| Day's range | 6.67 - 7.06 |
| Contract range | N/A |
| Volume | |
| Open interest | 5 |
Business WireKite Data at EHA 2024 Demonstrate Positive Patient Outcomes and Advances in Delivery of CAR T-cell Therapy
SANTA MONICA, Calif., May 14, 2024--Kite, a Gilead Company (Nasdaq: GILD), today announced 12 abstracts from its industry-leading Chimeric Antigen Receptor (CAR) T-cell therapy portfolio at the upcoming 2024 European Hematology Association (EHA) Annual Congress, June 13-16, Madrid, Spain.
Yahoo FinanceOne stock is dragging down the S&P 500's earnings growth
S&P 500 companies have had a solid Q1 earnings season, with one key exception: drugmaker Bristol Myers Squibb.
ZacksGilead Sciences, Inc. (GILD) is Attracting Investor Attention: Here is What You Should Know
Zacks.com users have recently been watching Gilead (GILD) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
© 2024 Yahoo. All rights reserved.